Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 13, 2017 - Issue 4
Submit an article Journal homepage
1,135
Views
24
CrossRef citations to date
0
Altmetric
Review

Standard and biological treatment in large vessel vasculitis: guidelines and current approaches

Francesco MuratoreRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, ItalyView further author information
,
Nicolò PipitoneRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, ItalyView further author information
&
Carlo SalvaraniRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, ItalyCorrespondence[email protected]
View further author information
Pages 345-360 | Received 25 Jul 2016, Accepted 19 Jan 2017, Published online: 06 Feb 2017

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michael Schirmer, Francesco Muratore & Carlo Salvarani. (2018) Tocilizumab for the treatment of giant cell arteritis. Expert Review of Clinical Immunology 14:5, pages 339-349.
Read now

Articles from other publishers (23)

Hugh D. Alessi, Kaitlin A. Quinn, Mark A. Ahlman, Elaine Novakovich, Babak Saboury, Yiming Luo & Peter C. Grayson. (2023) Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study . Arthritis Care & Research 75:6, pages 1362-1370.
Crossref
Kaitlin A. Quinn, Durga P. Misra, Aman Sharma, Andrew Porter, Justin Mason & Peter C. Grayson. 2023. A Clinician's Pearls & Myths in Rheumatology. A Clinician's Pearls & Myths in Rheumatology 447 464 .
Mohsen Tabatabaei & Baharak Tasorian. (2022) A Descriptive Case Series Study from 2009 to 2019 and a Brief Review on Takayasu’s Arteritis Patients in Arak. Jundishapur Journal of Chronic Disease Care 11:2.
Crossref
Michael Y Zhao, Ujalashah Dhanani, Chaow Charoenkijkajorn, Mohammad Pakravan, Peter W Mortensen & Andrew G Lee. (2022) Immunosuppressive Therapy in Giant Cell Arteritis: Do Steroids Still Reign Supreme?. US Ophthalmic Review 16:2, pages 85.
Crossref
Stephen P. McAdoo. 2022. Primer on Nephrology. Primer on Nephrology 489 504 .
Christopher David Box, Veena Dhillon & Barbara Hauser. (2021) Takayasu Arteritis. JCR: Journal of Clinical Rheumatology 27:8S, pages S406-S408.
Crossref
Francesco Muratore & Carlo Salvarani. (2021) Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab. Annals of the Rheumatic Diseases 80:7, pages e121-e121.
Crossref
Ana Leonor Rei da Cruz Escaleira, Dimitrios Kalogeropoulos, Chris Kalogeropoulos, Soon Wai Ch’Ng, Velota C T Sung, Ioannis Asproudis, Alexandra Papoudou-Bai, Konstantinos Malamos & Arijit Mitra. (2021) Four common diseases causing sudden blindness or death in the eye emergency department. Postgraduate Medical Journal 97:1146, pages 256-263.
Crossref
Farzana Shumy, AhmadMursel Anam, MinhajRahim Choudhury, MdAbu Shahin, SyedAtiqul Haq, MdZahid Amin & Sumayia Minhaj. (2021) Rate and predictors of response to glucocorticoid therapy in patients of takayasu arteritis at a tertiary level hospital of Bangladesh: A longitudinal study. Indian Journal of Rheumatology 16:4, pages 375.
Crossref
Haralampos M. Moutsopoulos & Evangelia Zampeli. 2021. Immunology and Rheumatology in Questions. Immunology and Rheumatology in Questions 205 243 .
L. Kollen, O. Werner & Arthur Gavotto. (2020) Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn’s Disease. Gastroenterology 158:8, pages 2055-2057.
Crossref
Chiara Marvisi, Eugenia Accorsi Buttini & Augusto Vaglio. (2020) Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases. La Presse Médicale 49:1, pages 104018.
Crossref
Anne Davidson & Betty Diamond. 2020. The Autoimmune Diseases. The Autoimmune Diseases 17 44 .
Mehdi Raza, Yasser El Maideny & Nadia Bokhari. (2019) Giant cell arteritis: advances in diagnosis and management. British Journal of Hospital Medicine 80:8, pages 448-455.
Crossref
V. A. Chernukha, D. S. Atarschikov, N. V. Khamnagdaeva & I. V. Pozharov. (2019) Giant Cell Arteritis in Ophthalmology Practice: a Case Report. Ophthalmology in Russia 16:1, pages 109-114.
Crossref
Dominika Podgórska, Rafał Podgórski, David Aebisher & Piotr Dąbrowski. (2019) Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment. Journal of Applied Biomedicine 17:1, pages 20-20.
Crossref
Enrico Tombetti & Justin C Mason. (2019) Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology 58:2, pages 206-219.
Crossref
Francesco Muratore, Stefania Croci, Alessandra Soriano, Nicolò Pipitone & Carlo Salvarani. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity 609 618 .
Giovanni Maria Rossi, Alessandro Mannoni, Gerardo Di Scala, Elena Silvestri, Rafaela Diana Cojan, Lorenzo Vannozzi, Alessandra Bettiol, Augusto Vaglio & Giacomo Emmi. (2018) Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial. Autoimmunity Reviews 17:12, pages 1265-1267.
Crossref
Žiga Rotar, Matija Tomšič & Alojzija Hočevar. (2018) Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis. Rheumatology 57:5, pages 934-936.
Crossref
Francesco Muratore, Giulia Pazzola, Alessandra Soriano, Nicolò Pipitone, Stefania Croci, Martina Bonacini, Luigi Boiardi & Carlo Salvarani. (2017) Unmet Needs in the Pathogenesis and Treatment of Vasculitides. Clinical Reviews in Allergy & Immunology 54:2, pages 244-260.
Crossref
Haralampos M. Moutsopoulos, Evangelia Zampeli & Panayiotis G. VlachoyiannopoulosHaralampos M. Moutsopoulos, Evangelia Zampeli & Panayiotis G. Vlachoyiannopoulos. 2018. Rheumatology in Questions. Rheumatology in Questions 153 175 .
Yasushi Kawaguchi. (2017) Contribution of Interleukin-6 to the Pathogenesis of Systemic Sclerosis. Journal of Scleroderma and Related Disorders 2:2_suppl, pages S6-S12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.